Haematologica (Apr 2017)

Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients

  • Michael Ghermezi,
  • Mingjie Li,
  • Suzie Vardanyan,
  • Nika Manik Harutyunyan,
  • Jillian Gottlieb,
  • Ariana Berenson,
  • Tanya M. Spektor,
  • Claudia Andreu-Vieyra,
  • Sophia Petraki,
  • Eric Sanchez,
  • Kyle Udd,
  • Cathy S. Wang,
  • Regina A. Swift,
  • Haiming Chen,
  • James R. Berenson

DOI
https://doi.org/10.3324/haematol.2016.150896
Journal volume & issue
Vol. 102, no. 4

Abstract

Read online

B-cell maturation antigen is expressed on plasma cells. In this study, we have identified serum B-cell maturation antigen as a novel biomarker that can monitor and predict outcomes for multiple myeloma patients. Compared to healthy donors, patients with multiple myeloma showed elevated serum B-cell maturation antigen levels (P